In the past 18 months, the FDA has approved two fecal microbiota products, Rebyota and Vowst, for treating recurrent Clostridioides…
Browsing: Clinical Updates
Exact Sciences has begun enrolling patients in its Multi-Cancer Early Detection (MCED) Falcon Registry study, aimed at evaluating the clinical…
The American College of Gastroenterology (ACG) and the American Society for Gastrointestinal Endoscopy (ASGE) have updated their quality indicators for…
A panel of 24 international experts developed 19 consensus statements to guide clinicians in referring patients with large nonpedunculated colorectal…
The FDA has approved Gilead Sciences’ drug Livdelzi (bulevirtide) for the treatment of primary biliary cholangitis (PBC), a chronic liver…
Johns Hopkins Kimmel Cancer Center has developed Esopredict, a PCR-based test that helps predict the progression of Barrett’s esophagus to…
The article discusses a study showing that a top-down treatment approach, which uses biologics early in therapy, appears more effective…
The study published in JAMA Network Open demonstrates that fecal immunochemical test (FIT) screening significantly reduces colorectal cancer (CRC) mortality…
A recent study published in The American Journal of Gastroenterology examines the risk of colorectal cancer following adenoma removal. The…
Guardant Health’s COSMOS study, published in Clinical Cancer Research, validates the effectiveness of the Guardant Reveal liquid biopsy test in…